Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022857037> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2022857037 endingPage "433" @default.
- W2022857037 startingPage "425" @default.
- W2022857037 abstract "PurposeTo evaluate the safety and efficacy of miglustat in patients with GM2 gangliosidosis.MethodsA randomized, multicenter, open-label, 12-month study involving patients aged 18 years or older, randomized 2:1 to miglustat (200 mg TID) or “no miglustat treatment.” This study was followed by 24 months of extended treatment during which all patients received miglustat. Primary efficacy endpoints were change in eight measures of isometric muscle strength in the limbs and isometric grip strength, evaluated at baseline, and months 12 and 36. Secondary efficacy endpoints included gait, balance, disability, and other neurological assessments. Safety evaluations included adverse event reporting.ResultsThirty patients (67% male, age range 18–56 years) with late-onset Tay-Sachs disease were enrolled; 20 were randomized to miglustat and 10 to “no miglustat treatment.” Muscle and grip strength generally decreased over the study period. No differences were observed between the two groups in any efficacy measure, either during the 12-month randomized phase or the full 36 months. The most common treatment-related adverse events were decrease in weight and diarrhea.ConclusionMiglustat treatment was not shown to lead to measurable benefits in this cohort of patients with late-onset Tay-Sachs disease. The observed safety profile was consistent with that of the approved dose (100 mg TID) in type 1 Gaucher disease." @default.
- W2022857037 created "2016-06-24" @default.
- W2022857037 creator A5014792309 @default.
- W2022857037 creator A5017093187 @default.
- W2022857037 creator A5032044332 @default.
- W2022857037 creator A5049974643 @default.
- W2022857037 creator A5062432540 @default.
- W2022857037 date "2009-06-01" @default.
- W2022857037 modified "2023-10-17" @default.
- W2022857037 title "Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment" @default.
- W2022857037 cites W4237126259 @default.
- W2022857037 doi "https://doi.org/10.1097/gim.0b013e3181a1b5c5" @default.
- W2022857037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19346952" @default.
- W2022857037 hasPublicationYear "2009" @default.
- W2022857037 type Work @default.
- W2022857037 sameAs 2022857037 @default.
- W2022857037 citedByCount "87" @default.
- W2022857037 countsByYear W20228570372012 @default.
- W2022857037 countsByYear W20228570372013 @default.
- W2022857037 countsByYear W20228570372014 @default.
- W2022857037 countsByYear W20228570372015 @default.
- W2022857037 countsByYear W20228570372016 @default.
- W2022857037 countsByYear W20228570372017 @default.
- W2022857037 countsByYear W20228570372018 @default.
- W2022857037 countsByYear W20228570372019 @default.
- W2022857037 countsByYear W20228570372020 @default.
- W2022857037 countsByYear W20228570372021 @default.
- W2022857037 countsByYear W20228570372022 @default.
- W2022857037 countsByYear W20228570372023 @default.
- W2022857037 crossrefType "journal-article" @default.
- W2022857037 hasAuthorship W2022857037A5014792309 @default.
- W2022857037 hasAuthorship W2022857037A5017093187 @default.
- W2022857037 hasAuthorship W2022857037A5032044332 @default.
- W2022857037 hasAuthorship W2022857037A5049974643 @default.
- W2022857037 hasAuthorship W2022857037A5062432540 @default.
- W2022857037 hasBestOaLocation W20228570371 @default.
- W2022857037 hasConcept C126322002 @default.
- W2022857037 hasConcept C141071460 @default.
- W2022857037 hasConcept C168563851 @default.
- W2022857037 hasConcept C187212893 @default.
- W2022857037 hasConcept C197934379 @default.
- W2022857037 hasConcept C203092338 @default.
- W2022857037 hasConcept C2777433710 @default.
- W2022857037 hasConcept C71924100 @default.
- W2022857037 hasConceptScore W2022857037C126322002 @default.
- W2022857037 hasConceptScore W2022857037C141071460 @default.
- W2022857037 hasConceptScore W2022857037C168563851 @default.
- W2022857037 hasConceptScore W2022857037C187212893 @default.
- W2022857037 hasConceptScore W2022857037C197934379 @default.
- W2022857037 hasConceptScore W2022857037C203092338 @default.
- W2022857037 hasConceptScore W2022857037C2777433710 @default.
- W2022857037 hasConceptScore W2022857037C71924100 @default.
- W2022857037 hasIssue "6" @default.
- W2022857037 hasLocation W20228570371 @default.
- W2022857037 hasLocation W20228570372 @default.
- W2022857037 hasOpenAccess W2022857037 @default.
- W2022857037 hasPrimaryLocation W20228570371 @default.
- W2022857037 hasRelatedWork W1556819926 @default.
- W2022857037 hasRelatedWork W2063093419 @default.
- W2022857037 hasRelatedWork W2112436308 @default.
- W2022857037 hasRelatedWork W2153961034 @default.
- W2022857037 hasRelatedWork W2355769538 @default.
- W2022857037 hasRelatedWork W2362391294 @default.
- W2022857037 hasRelatedWork W2373885168 @default.
- W2022857037 hasRelatedWork W2565664823 @default.
- W2022857037 hasRelatedWork W3139914494 @default.
- W2022857037 hasRelatedWork W4245168056 @default.
- W2022857037 hasVolume "11" @default.
- W2022857037 isParatext "false" @default.
- W2022857037 isRetracted "false" @default.
- W2022857037 magId "2022857037" @default.
- W2022857037 workType "article" @default.